Department of Thoracic Surgery, Suzhou Wujiang District First People's Hospital, Songling Town, Wujiang District, Suzhou City, Jiangsu Province, China.
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):142-149. doi: 10.26355/eurrev_201801_14111.
To investigate the relative expression of long non-coding RNA (lncRNA) ASAP1-IT1 (hereafter called ASAP1-IT1) in tissues and cells of non-small cell lung cancer (NSCLC) patients, so as to explore the effect of ASAP1-IT1 on the biological effect of NSCLC cells.
Real-time quantitative polymerase chain reaction (qRT-PCR) was performed to detect the relative expressions of ASAP1-IT1 on tissues of 68 NSCLC patients and 5 cell lines. Besides, the interference sequence of ASAP1-IT1 was designed to detect the transfection efficiency through qRT-PCR experiment. Cell count kit 8 (CCK-8) and clone formation experiment were also carried out to determine the effect of ASAP1-IT1 expression under interference on the proliferation ability of NSCLC cells. In addition, transwell experiment was also performed to investigate the effects of ASAP1-IT1 expression under interference on the invasion and metastasis of NSCLC cells. Furthermore, the Western blotting assay was also conducted to detect the downstream signal pathways through which ASAP1-IT1 regulated the biological behaviors of NSCLC.
The results of qRT-PCR experiment showed that in 68 NSCLC samples, upregulation of ASAP1-IT1 expression was identified in 51 samples (82.4%) in comparison with the expression in tumor-adjacent tissues, and a similar upregulation was also observed in 5 NSCLC cells. CCK-8 and clone formation experiments also revealed that interference on ASAP1-IT1 expression could inhibit the proliferation of NSCLC cells, while the transwell experiment showed that the interference on ASAP1-IT1 expression could block the migration and invasion ability of NSCLC cells. The results of Western blotting assay also indicated that ASAP1-IT1 could regulate the biological behaviors of NSCLC cells through phosphatase and tensin homolog deleted on chromosome ten (PTEN)/serine-threonine kinase (AKT) pathway.
In this study, it was found that the expression of ASAP1-IT1 is relatively upregulated in NSCLC cells and tissues, which can promote the proliferation, invasion and metastasis of NSCLC cells through regulating the PTEN/AKT signal pathway. Thus, the therapeutic target of ASAP1-IT1 is expected to provide important ideas for reversing the malignant phenotype of NSCLC in clinical practice.
检测长链非编码 RNA(lncRNA)ASAP1-IT1(以下简称 ASAP1-IT1)在非小细胞肺癌(NSCLC)患者组织和细胞中的相对表达水平,以探讨 ASAP1-IT1 对 NSCLC 细胞生物学功能的影响。
采用实时荧光定量聚合酶链反应(qRT-PCR)检测 68 例 NSCLC 患者和 5 种细胞系组织中 ASAP1-IT1 的相对表达情况。此外,设计 ASAP1-IT1 的干扰序列,通过 qRT-PCR 实验检测转染效率。细胞计数试剂盒 8(CCK-8)和克隆形成实验也用于确定干扰 ASAP1-IT1 表达对 NSCLC 细胞增殖能力的影响。此外,还进行了 Transwell 实验,以研究干扰 ASAP1-IT1 表达对 NSCLC 细胞侵袭和转移的影响。进一步通过 Western blot 实验检测 ASAP1-IT1 通过调节 NSCLC 细胞生物学行为的下游信号通路。
qRT-PCR 实验结果显示,在 68 例 NSCLC 样本中,与肿瘤旁组织相比,51 例(82.4%)样本中 ASAP1-IT1 表达上调,5 种 NSCLC 细胞中也观察到类似的上调。CCK-8 和克隆形成实验还表明,干扰 ASAP1-IT1 表达可抑制 NSCLC 细胞的增殖,而 Transwell 实验表明,干扰 ASAP1-IT1 表达可阻断 NSCLC 细胞的迁移和侵袭能力。Western blot 实验结果也表明,ASAP1-IT1 可通过磷酸酶和张力蛋白同源物缺失的染色体 10(PTEN)/丝氨酸-苏氨酸激酶(AKT)通路调节 NSCLC 细胞的生物学行为。
本研究发现,ASAP1-IT1 在 NSCLC 细胞和组织中相对高表达,可通过调节 PTEN/AKT 信号通路促进 NSCLC 细胞的增殖、侵袭和转移。因此,ASAP1-IT1 的治疗靶点有望为临床实践中逆转 NSCLC 的恶性表型提供重要思路。